1. "Robert Tuttle"
  2. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (40)
  2. Meeting Abstract (7)
  3. Book Section (3)
  4. Editorial (1)
Groups
  1. Department of Medicine (51)
  2. Division of Subspecialty Medicine (51)
  3. Endocrinology (51)
  4. Molecular Imaging and Therapy Service (51)
  5. Radiology, Department of (51)
  6. Survivorship Research (51)

More Groups

People
  1. Robert Tuttle (51)
  2. Steven Larson (36)
  3. Ravinder Grewal (28)
  4. Ronald Ghossein (18)
  5. Alan Ho (13)
  6. James Fagin (12)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (3)
  4. 2020 (1)
  5. 2019 (2)
  6. 2017 (2)

More Years

Publications
  1. Journal of Nuclear Medicine (12)
  2. Thyroid (11)
  3. Journal of Clinical Endocrinology and Metabolism (7)
  4. Journal of Clinical Oncology (6)
  5. European Journal of Nuclear Medicine and Molecular Imaging (3)
  6. Cancer (2)

More Publications

Publishers
  1. Society of Nuclear Medicine (12)
  2. Mary Ann Liebert, Inc (11)
  3. Oxford University Press (7)
  4. American Society of Clinical Oncology (6)
  5. Springer (5)
  6. Wiley Blackwell (3)

More Publishers

Results (51)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: Overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
    Editorial

    Bodei, L.; Tuttle, R. M.; Grewal, R. K.; Mauguen, A.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J. R.; Haque, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): A regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients
    Journal Article

    Mauguen, A.; Grewal, R. K.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J.; Haque, S.; Wong, B. Z. Y.; Ghossein, R. A.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)
    Meeting Abstract

    Burman, B.; Tuttle, R. M.; Grewal, R. K.; Sherman, E. J.; Baxi, S. S.; Boucai, L.; Sabra, M.; Fish, S.; Pentlow, K. S.; Haque, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinicopathologic and prognostic features of pediatric follicular cell-derived thyroid carcinomas: A retrospective study of 222 patients
    Journal Article

    Saliba, M.; Alzumaili, B. A.; Katabi, N.; Dogan, S.; Tuttle, R. M.; Zoltan, A.; Pandit-Taskar, N.; Xu, B.; Ghossein, R. A.
    American Journal of Surgical Pathology (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers
    Meeting Abstract

    Burman, B.; Sherman, E. J.; Kriplani, A.; Michel, L. S.; Dunn, L.; Fetten, J. V.; Warner, E.; Grewal, R. K.; Sabra, M.; Tuttle, R. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase 2 study of vascular endothelial growth factor trap for the treatment of metastatic thyroid cancer
    Journal Article

    Sherman, E. J.; Dunn, L. A.; Schòˆder, H.; Ho, A. L.; Baxi, S. S.; Ghossein, R. A.; Haque, S. S.; Sima, C.; Tuttle, R. M.; Pfister, D. G.
    Cancer (2019)

    Fulltext@MSK | Save
  • Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers
    Journal Article

    Dunn, L. A.; Sherman, E. J.; Baxi, S. S.; Tchekmedyian, V.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Journal of Clinical Endocrinology and Metabolism (2019)

    Fulltext@MSK | Save
  • Redifferentiating thyroid cancer: Selumetinib-enhanced radioiodine uptake in thyroid cancer
    Journal Article

    Larson, S. M.; Osborne, J. R.; Grewal, R. K.; Tuttle, R. M.
    Molecular Imaging and Radionuclide Therapy (2017)

    Fulltext@MSK | Save
  • Comparison of empiric versus whole-body/-blood clearance dosimetry-based approach to radioactive iodine treatment in patients with metastases from differentiated thyroid cancer
    Journal Article

    Deandreis, D.; Rubino, C.; Tala, H.; Leboulleux, S.; Terroir, M.; Baudin, E.; Larson, S.; Fagin, J. A.; Schlumberger, M.; Tuttle, R. M.
    Journal of Nuclear Medicine (2017)

    Fulltext@MSK | Save